The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Spectrum Pharmaceuticals Inc

Nasdaq: SPPI
Last

(U.S.) $7.61

Today's change-0.25 -3.18%
Updated April 28 4:00 PM EDT. Delayed by at least 15 minutes.
 

Spectrum Pharmaceuticals Inc

Nasdaq: SPPI
Last

(U.S.) $7.61

Today's change-0.25 -3.18%
Updated April 28 4:00 PM EDT. Delayed by at least 15 minutes.

Spectrum Pharmaceuticals Inc down (U.S.)$0.25

Spectrum Pharmaceuticals Inc closed sharply lower Friday, dropping (U.S.)$0.25 or 3.18% to (U.S.)$7.61. Over the last five days, shares have gained 7.33% and are currently 4.88% off of the 52-week high. Shares have underperformed the S&P 500 by 8.57% during the last year.

Key company metrics

  • Open(U.S.) $7.85
  • Previous close(U.S.) $7.86
  • High(U.S.) $7.89
  • Low(U.S.) $7.58
  • Bid / Ask(U.S.) $2.95 / (U.S.) $8.35
  • YTD % change+71.78%
  • Volume686,474
  • Average volume (10-day)984,571
  • Average volume (1-month)866,726
  • Average volume (3-month)747,320
  • 52-week range(U.S.) $3.21 to (U.S.) $8.00
  • Beta1.43
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.93
Updated April 28 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.51%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue35333444
Total other revenue--------
Total revenue35333444
Gross profit24242637
Total cost of revenue111087
Total operating expense53495650
Selling / general / administrative18192822
Research & development16131415
Depreciation / amortization7766
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-17-16-22-6
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-19-18-24-9
Income after tax-17-17-24-9
Income tax, total-2000
Net income-17-17-24-9
Total adjustments to net income--------
Net income before extra. items-17-17-24-9
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-17-17-24-9
Inc. avail. to common incl. extra. items-17-17-24-9
Diluted net income-17-17-24-9
Dilution adjustment--------
Diluted weighted average shares80796966
Diluted EPS excluding extraordinary itemsvalue per share-0.22-0.22-0.35-0.14
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.22-0.22-0.35-0.14